July 28 (Reuters) – Lepu Biopharma Co Ltd: * REPORTS POSITIVE TOP-LINE RESULTS FROM GLOBAL PHASE III TRIAL OF CMG901 (AZD0901) Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Valencia appoint former Mexico coach Aguirre after disappointing start
VIDEO SHOWS: ARCHIVE FOOTAGE OF JAVIER AGUIRRE AS HE IS APPOINTED VALENCIA HEAD COACH SHOWS:…
BRIEF-Sidike New Materials Science & Technology Plans To Invest In BOPET Base Film Expansion Project
Sept 23 (Reuters) - Jiangsu Sidike New Materials Science & Technology Co Ltd: * SAYS…
China chipmaker CanSemi seeks to raise up to $918.5 million in Shenzhen listing
HONG KONG, Sept 23 (Reuters) - Chinese chipmaker CanSemi Technology is seeking to raise 6.16…
